Alzheimer's Disease Clinical Research Trials

Active

A Randomized, Placebo Controlled, Parallel-Group, Double Blind Efficacy and Safety Trial of MK-8931 with a Long Term Double-Blind Extension in Subjects with Mild to Moderate Alzheimer’s Disease (MK-8931-017)

  • Status:Enrolling
  • Sponsor: Merck Sharp & Dohme Corp.
  • Click here for more information

A Seamless Phase IIa/IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial to Evaluate the Efficacy and Safety of MK-7622 as an Adjunctive Therapy to Donepezil for Symptomatic Treatment in Subjects with Alzheimer’s disease

  • Status:Enrolling
  • Sponsor: Merck Sharp & Dohme Corp.
  • Click here for more information

A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer’s Disease

  • Status:Enrolling
  • Sponsor: Eisai, Inc.
  • Click here for more information

Completed

Effect of Passive Immunization on the Progression of Mild Alzheimer’s Disease: Solanezumab (LY2062430) Versus Placebo

  • Status:Not Enrolling
  • Sponsor: Eli Lilly and Company
  • Click here for more information